Most Effective Tongue Cancer Treatment With Low Side Effects

What is Hyperthermia? Hyperthermia is a heat cancer treatment applied locally to tumors, raising tumor temperature to about 42.5(108) for about 45 to 60 minutes. Heat improves blood circulation and makes tumor cells more susceptible to radiation therapy, killing them more efficiently and quickly. Hyperthermia can be compared with an artificial fever that attacks cancer cells. The combination of both, hyperthermia and low dose radiation makes this therapy the most efficient cancer treatment available today.

Hyperthermia combined with low dose radiation is a very effective treatment for most cases of cancer. The side effects are minimum, and the body has the ability to recover from the low dose radiation in most cases.

What type of tumors are treated using Hyperthermia? In VCI (Valley Cancer Institute) state-of-the-art facility treats a wide range of tumors. Many are in difficult-to-reach sites that have not responded well to other treatment methods.

Effective treatable sites: Brain, bone, throat, thyroid, breast, colon, head and neck, base of tongue, tonsils, prostate, skin, and other anatomical sites.

Types of treatable tumors: Adenocarcinoma, Carcinoma, Thymoma, Squamous Cell, Mesothelioma, Sarcoma, Melanoma, Lymphoma, Basal Cell.

Valley Cancer Institute added IMRT capabilities in 2007, to the Hyperthermia plus low dose radiation treatment. IMRT, Intensity-Modulated Radiation Therapy, is a modality of radiation therapy in which the radiation beam is shaped and targeted only to the tumor area that needs to be treated, avoiding radiation exposure to the surrounded areas. The IMRT treatment therapy is very accurate, and used to deliver precise radiation doses to a malignant tumor or specific areas within the tumor, while minimizing the dose to surrounding normal tissue areas. Hyperthermia and low dose radiation delivered through IMRT, is an excellent and very effective therapy combination for most superficial cancer tumors, and in many cases they can be treated with a curative intent.

Hyperthermia has been proven to increase the response of malignant tumors to radiation therapy in both experimental animal tumors and the clinical treatment of human cancer. Based on our multi-year experience, first in re-treatment of previously radiated fields that necessitated the use of low dose radiation fractions as adjunct to the heat treatments, and then progressively applying the encouraging results obtained to areas treated "de novo" and eventually to situations allowing a potentially curative intent, treatment protocols have been devised and tested that yield positive preliminary data showing superior tumor response rates and less side effects when compared with historical controls at our Institute.

The hyperthermia part of the protocol extends the number of heat treatments to correspond to the number of radiation-fractions, as each hyperthermia treatment proceeds or follows each radiation treatment in close time proximity. The number of hyperthermia treatments therefore varies from 25-50 per course for each treated field. Outcomes confirm that more Hyperthermia fractions improve both tumor response and survival.

The radiation protocol consists of progressively decreasing daily doses of radiation therapy combined with the daily hyperthermia treatments. Typically the treatment is started at a daily dose of 180cGy gradually reduced to 100cGy protracting a typical radiation therapy treatment course from 5000cGy in five weeks to 5000cGy given in over eight weeks; or 7000cGy in seven weeks to 7000cGy in 14 weeks. According to the ELLIS TDF formula, this results in a 15% or 25% reduction of the effective radiation dose. The total dose is of course adapted to the clinical situation. To this effect, the use of objective end result parameters is introduced, including MR Spectroscopy, PET Scanning and Tumor Marker levels. Increased radiation doses improve tumor response, but not survival, when enough Hyperthermia is given. Increased Hyperthermia doses, increase both response and survival.

http://vci.org Since its inception in 1984 Valley Cancer Institute has been committed to the research, development, and clinical use of Hyperthermia, a natural, less toxic cancerocidal modality, to improve cancer treatment results while decreasing side effects of conventional therapies. Hyperthermia and low dose radiation given at the Valley Cancer Institute, is a cutting edge technology delivered with curative intent.

Valley Cancer Institute is one of the largest Hyperthermic research and clinic treatment center in the USA. The Institute encompasses over 7,000 sq. ft. in Los Angeles, California, USA, conveniently located near the Los Angeles International Airport.

Capable of treating up to 30 patients per day, Valley Cancer Institute offers the most advanced hyperthermic technology (hyperthermia alternative cancer treatment) with five Hyperthermia treatment areas, and full radiation and medical oncology departments. Using a HOLISTIC approach, the combination of the natural heat treatment with the other established anti-cancer modalities, allows for good treatment results in most tumors, while markedly decreasing the level of toxicity.

Valley Cancer Institute 12099 W. Washington Blvd.,#304 Los Angeles, CA 90066 310) 398.0013 http://vci.org

Comment on "Most Effective Tongue Cancer Treatment With Low Side Effects"